Discover 3,073 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,073
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
for
Prostate Cancer
Location: Houston TX, Spring TX, Austin TX, San Antonio TX,
Sponsor: AstraZeneca
Sex: Male
Age: 18+
Code: NCT06952803
Phase3, Recruiting
ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
for
HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer
Location: Houston TX, Sarasota FL, New Haven CT, Orlando FL,
Sponsor: Avenzo Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06998407
Phase1, Phase2, Recruiting
Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma
for
Cutaneous Squamous Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06567314
Phase2, Recruiting
A Phase I Study of Hyper-CVAD In Combination With Venetoclax In Pediatric Patients With Relapsed or Refractory Acute Leukemias That Are of the Lymphoid Lineage Including Bi-Phenotypic or Undifferentiated Leukemias
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor
for
Advanced Liver Cancer
Location: Houston TX, Tampa FL, Jacksonville FL, Rochester MN,
Sponsor: Abbisko Therapeutics Co, Ltd
Sex: All
Age: 18 - 70+
Code: NCT04906434
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
SLV-324 Treatment of Metastatic Solid Tumors
for
Metastatic Solid Tumors
Location: Houston TX, St Louis MO, Cleveland OH, Philadelphia PA,
Sponsor: Solve Therapeutics
Sex: All
Age: 18+
Code: NCT07108114
Phase1, Recruiting
Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases
for
Metastases
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05195710
Phase1, Recruiting
A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma
for
Solid Tumor, Adult, Lymphoma
Location: Houston TX, Duarte CA
Sponsor: Cyclacel Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT04983810
Phase1, Phase2, Recruiting
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
for
Rhinovirus Infection
Location: Tomball TX, Lewisville TX, Edmond OK, Mobile AL,
Sponsor: Altesa Biosciences, Inc.
Sex: All
Age: 40 - 70+
Code: NCT07610395
Phase2, Recruiting
CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers
for
Metastatic Biliary Tract Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06548412
Phase1, Phase2, Recruiting
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
for
Lupus Nephritis
Location: Bellaire TX, Houston TX, Lake Charles LA, Van Vleck TX,
Sponsor: Aurinia Pharmaceuticals Inc.
Sex: All
Age: 18 - 70+
Code: NCT07611214
Recruiting
A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors
for
Locally Advanced (Unresectable) or Metastatic Solid Tumors
Location: Houston TX, Austin TX, Dallas TX, San Antonio TX,
Sponsor: NEOK Bio, Inc.
Sex: All
Age: 18+
Code: NCT07612189
Phase1, Recruiting
A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
for
Hematologic Neoplasms
Location: Houston TX, Nashville TN, Indianapolis IN,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07572006
Phase1, Recruiting
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma